Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies
Jazyk angličtina Země Rakousko Médium print
Typ dokumentu časopisecké články
PubMed
9681044
Knihovny.cz E-zdroje
- MeSH
- acyklovir terapeutické užití MeSH
- aktivace viru účinky léků MeSH
- antivirové látky terapeutické užití MeSH
- diferenciální diagnóza MeSH
- dospělí MeSH
- hematologické nádory terapie MeSH
- herpes simplex farmakoterapie etiologie MeSH
- horečka neznámého původu farmakoterapie etiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- neutropenie farmakoterapie etiologie MeSH
- oportunní infekce farmakoterapie etiologie MeSH
- retrospektivní studie MeSH
- senioři MeSH
- stomatitida farmakoterapie etiologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- acyklovir MeSH
- antivirové látky MeSH
Mucositis is a common complication following chemotherapy. Clinical findings similar to herpetic infection are observed in some patients. Acyclovir administered in addition to empirical, antibiotic treatment improves the course of mucositis, and can also bring down the temperature. The aim of our study was to define the etiological influence of herpetic infection on the course of febrile neutropenia in patients with mucositis. A total of 34 patients with febrile neutropenia were divided into 2 groups: 15 with typical herpetic eruption, and 19 with non-specific mucositis. Both groups received 5-10 mg/kg acyclovir every eight hours together with empiric antibiotic treatment. The effect of acyclovir was studied, and results compared in the two patient groups. Body temperatures decreased in both groups, clinical symptoms, however, disappeared more slowly in the group with non-specific mucositis. The beneficial effect of acyclovir treatment was particularly well expressed in seropositive patients. In this group of patients, herpetic infections may recur under further chemotherapy. Thus, it would be useful to administer acyclovir to them prophylactically during risk periods.